FIGURE 1.

Median and interquartile ranges of AKS‐218d dose, serum AKS‐218d concentrations, and interstitial glucose (IG, mean over the preceding week) in 5 dogs treated with AKS‐218d once‐weekly. All dogs were treated with an intermediate‐acting insulin on week 0 and received the first dose of study insulin (AKS‐218d) on week 1. For each week, AKS‐218d concentrations represent the value that was obtained in the visit following the dose that correspond to the same week number. Similarly, week IG mean represent the mean of the week that followed that same dose